1. Home
  2. FTAIN vs HUMAW Comparison

FTAIN vs HUMAW Comparison

Compare FTAIN & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FTAIN

FTAI Aviation Ltd. 8.25% Fixed - Rate Reset Series C Cumulative Perpetual Redeemable Preferred Shares

HOLD

Current Price

$25.38

Market Cap

0.0

Sector

Industrials

ML Signal

HOLD

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

HOLD

Current Price

$0.08

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTAIN
HUMAW
Founded
N/A
2004
Country
United States
United States
Employees
985
184
Industry
Misc Corporate Leasing Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FTAIN
HUMAW
Price
$25.38
$0.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.5K
14.5K
Earning Date
N/A
03-21-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.56
$0.06
52 Week High
$25.89
$0.60

Technical Indicators

Market Signals
Indicator
FTAIN
HUMAW
Relative Strength Index (RSI) 58.98 43.88
Support Level $25.32 $0.06
Resistance Level $25.70 $0.10
Average True Range (ATR) 0.04 0.01
MACD 0.02 -0.00
Stochastic Oscillator 100.00 33.33

Price Performance

Historical Comparison
FTAIN
HUMAW

About FTAIN FTAI Aviation Ltd. 8.25% Fixed - Rate Reset Series C Cumulative Perpetual Redeemable Preferred Shares

FTAI Aviation Ltd is an independent engine maintenance platform focused on the CFM56-5B, CFM56-7B, and V2500 aircraft engines, which power the 737NG and A320ceo aircraft. The company repairs and rebuilds engines in its maintenance facilities and with joint venture partners, and sells or leases engines through its proprietary Maintenance, Repair and Exchange (MRE) model under the Aerospace Products segment, which earns maximum revenue from North America and develops, repairs/refurbishes, and sells aircraft engines and aftermarket components. It also operates an Aviation Leasing segment, owning and managing a portfolio of on- and off-lease aircraft and engines, including engine transfers for rebuilding and sales.

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: